CATX
Price
$3.71
Change
+$0.03 (+0.82%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
273.16M
Earnings call today
PROF
Price
$5.63
Change
+$0.09 (+1.62%)
Updated
Aug 11, 04:32 PM (EDT)
Capitalization
169.07M
3 days until earnings call
Interact to see
Advertisement

CATX vs PROF

Header iconCATX vs PROF Comparison
Open Charts CATX vs PROFBanner chart's image
Perspective Therapeutics
Price$3.71
Change+$0.03 (+0.82%)
Volume$3.46K
Capitalization273.16M
Profound Medical
Price$5.63
Change+$0.09 (+1.62%)
Volume$323
Capitalization169.07M
CATX vs PROF Comparison Chart in %
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. PROF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and PROF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (CATX: $3.68 vs. PROF: $5.54)
Brand notoriety: CATX and PROF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CATX: 33% vs. PROF: 65%
Market capitalization -- CATX: $276.13M vs. PROF: $168.42M
CATX [@Medical/Nursing Services] is valued at $276.13M. PROF’s [@Medical/Nursing Services] market capitalization is $168.42M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.63B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CATX and PROF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 4 TA indicator(s) are bullish while PROF’s TA Score has 2 bullish TA indicator(s).

  • CATX’s TA Score: 4 bullish, 3 bearish.
  • PROF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CATX is a better buy in the short-term than PROF.

Price Growth

CATX (@Medical/Nursing Services) experienced а 0.00% price change this week, while PROF (@Medical/Nursing Services) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.

Reported Earning Dates

CATX is expected to report earnings on Nov 18, 2025.

PROF is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($273M) has a higher market cap than PROF($169M). CATX YTD gains are higher at: 15.361 vs. PROF (-26.232). PROF has higher annual earnings (EBITDA): -35.5M vs. CATX (-83.95M). CATX has more cash in the bank: 212M vs. PROF (46.4M). CATX has less debt than PROF: CATX (3.82M) vs PROF (4.88M). PROF has higher revenues than CATX: PROF (11.9M) vs CATX (0).
CATXPROFCATX / PROF
Capitalization273M169M162%
EBITDA-83.95M-35.5M236%
Gain YTD15.361-26.232-59%
P/E RatioN/AN/A-
Revenue011.9M-
Total Cash212M46.4M457%
Total Debt3.82M4.88M78%
FUNDAMENTALS RATINGS
CATX vs PROF: Fundamental Ratings
CATX
PROF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4961
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (44) in the null industry is in the same range as CATX (63) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

PROF's Profit vs Risk Rating (100) in the null industry is in the same range as CATX (100) in the Biotechnology industry. This means that PROF’s stock grew similarly to CATX’s over the last 12 months.

CATX's SMR Rating (97) in the Biotechnology industry is in the same range as PROF (98) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's Price Growth Rating (49) in the Biotechnology industry is in the same range as PROF (61) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

CATX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PROF (100) in the null industry. This means that CATX’s stock grew similarly to PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CATXPROF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 22 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKKGY25.390.85
+3.46%
Merck KGaA
CSDX0.07N/A
+3.07%
CS Diagnostics Corp.
JDVB26.020.01
+0.04%
JD Bancshares, Inc.
FLTLF28.97N/A
N/A
FLOW TRADERS LTD.
TPGTF3.55N/A
N/A
TPG Telecom Ltd

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+1.38%
STRR - CATX
81%
Closely correlated
+0.50%
RBOT - CATX
40%
Loosely correlated
+4.48%
SHC - CATX
36%
Loosely correlated
+24.51%
BJDX - CATX
33%
Loosely correlated
-4.76%
MTD - CATX
30%
Poorly correlated
+1.54%
More

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and MTD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and MTD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-2.29%
MTD - PROF
28%
Poorly correlated
+1.54%
NYXH - PROF
26%
Poorly correlated
-1.07%
A - PROF
26%
Poorly correlated
+0.56%
QTRX - PROF
24%
Poorly correlated
-13.79%
CATX - PROF
24%
Poorly correlated
+1.38%
More